News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Erman Akkus: Role of PD-L1 expression in advanced esophageal SCC by Manavi Sachdeva et al.
cancercenter.com
Dec 25, 2024, 01:52

Erman Akkus: Role of PD-L1 expression in advanced esophageal SCC by Manavi Sachdeva et al.

A recent paper by Manavi Sachdeva, Senior Resident of Medical Oncology at National University Cancer Institute of Singapore, published in ESMO Gastrointestinal Oncology, was mentioned by Erman Akkus, Medical Oncology fellow at Ankara University, on X:

“Role of PD-L1 expression in advanced esophageal SCC treated with chemotherapy alone.

High expression – decreased OS.

“PD-L1 expression as a negative predictive biomarker in advanced esophageal squamous-cell cancer treated with chemotherapy alone”

Authors: Manavi Sachdeva et al.

Erman Akkus: Role of PD-L1 expression in advanced esophageal SCC by Manavi Sachdeva et al.

 

More posts featuring Erman Akkus.

Erman Akkus is a medical oncology fellow at the Ankara University, Faculty of Medicine. Previously, he was an Internal Medicine Resident at the Ankara University, Faculty of Medicine. He was also a Visiting Researcher at the University of Oslo. He completed his education from the Medical University of Vienna.

cancer Erman Akkus ESCC ESMO Gastrointestinal Oncology esophageal squamous cell carcinoma Manavi Sachdeva OncoDaily Oncology PD-L1 expression
Special Coverage
Science
Dec 25, 2024, 01:52
Erman Akkus: Role of PD-L1 expression in advanced esophageal SCC by Manavi Sachdeva et al.
Blog
Dec 25, 2024, 01:50
Results of SISAQOL-IMI: Advancing Patient-Reported Outcomes Research
Science
Dec 24, 2024, 23:45
Tatiana Prowell: Genomic profiling performed on 822 breast cancer brain metastases by Athina Giannoudis et al.
Blog
Dec 24, 2024, 23:42
Extending the pandemic-era telehealth flexibilities in Medicare - ASCO
Science
Dec 24, 2024, 23:36
Drew Moghanaki: An updated report from the MISSILE study team
Science
Dec 24, 2024, 23:31
Bladder-sparing Therapy for BCG-unresponsive Non-muscle-invasive Bladder Cancer
Insight
Dec 24, 2024, 23:29
Mark Bolton: What if patients switch treatment at progression
Blog
Dec 24, 2024, 23:27
Give the gift of hope, brighter futures, and more time for patients and families - The Leukemia And Lymphoma Society
Blog
Dec 24, 2024, 23:24
Shaban Juma: Community health education is the key component in disease prevention
Blog
Dec 24, 2024, 23:21
Christos Tsagkaris: Delivering a talk about secondary research at Attikon University Hospital
Blog
Dec 24, 2024, 23:17
Senator Tim Kaine honors Gabriella Miller's legacy in pediatric cancer research
Insight
Dec 24, 2024, 18:19
ICR’s spinout company “Sentinal4D” has officially been launched